The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for Immunotherapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed, 22 citations in OpenAlex.

1. IL-15/NKG2D signaling-mediated activation of CD8Journal of thoracic disease · 2026
   Article
2. ST8Sia6-dependent glycosylation restrains gut inflammation and pathogenic TCell reports · 2026
   Article
3. Polyclonal evolution of lymphoproliferative disorders in XLP1.Journal of human immunity · 2026
   Article
4. The roles and heterogeneity of CD8International journal of molecular medicine · 2026
   Review
5. Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies-a narrative review.Translational cancer research · 2026
   Review
6. Danger or Salvation? The Role of DAMPs in Cancer Therapy.Cancers · 2026
   Review
7. [Research progress of the ULBP-NKG2D axis in autoimmune diseases].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
   Review
8. Cytotoxic CD4Signal transduction and targeted therapy · 2026
   Review
9. Targeting NKG2D/NKG2DL axis in cancer immunotherapy: mechanisms and therapeutic applications.Journal of translational medicine · 2026
   Review
10. Combined carbon ion radiotherapy and immunotherapy: leveraging the immunological advantages of carbon ion.Frontiers in immunology · 2026
    Review
11. NKG2D CAR-T cells for solid tumor immunotherapy: advances, challenges, and future directions.Frontiers in immunology · 2026
    Review
12. IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives.Frontiers in medicine · 2026
    Review
13. Immune mechanisms in the pathogenesis of endometriosis: a comprehensive analysis of the role of NK cells, cytokines, and extracellular vesicles/exosomes.Frontiers in immunology · 2026
    Review
14. Mitochondria: from powerhouses of cells to hubs in antitumor immunity.Frontiers in immunology · 2026
    Review
15. The Metabolic Regulation of the NKG2D-Positive NK and T Cells and Their Role in Disease Progression.Biomolecules · 2025
    Review
16. Novel and recurrent mutations in exon 8 of natural killer group 2D (NKG2D) gene among chronic myeloid leukemia patients and their potential role in pathogenesis.Molecular biology reports · 2025
    Article
17. The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis.Scientific reports · 2025
    Article
18. The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccination.Nature cardiovascular research · 2025
    Article
19. Impaired immune reconstitution in HIV infection: the role of CD4Frontiers in immunology · 2025
    Article
20. Exploring the Role of Cellular Interactions in the Colorectal Cancer Microenvironment.Journal of immunology research · 2025
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as